Last updated: August 17, 2025
Introduction
South Korean patent KR20150003344 pertains to a method or composition related to drug development, with specific claims designed to protect innovative aspects of pharmaceutical formulations, mechanisms, or methods of manufacture. This patent provides crucial insights into the patent landscape within the rapidly evolving South Korean biopharmaceutical sector, particularly in areas such as biologics, small molecules, or targeted therapies. Analyzing its scope and claims helps stakeholders understand the competitive landscape, freedom to operate, and opportunities for new innovation.
Patent Identification and Overview
Patent Number: KR20150003344
Filing/Grant Date: Considering the number pattern and typical patent timelines, this patent likely was filed around 2013-2014 and granted in 2015.
Applicant/Assignee: If specified, the patent applicant might be a South Korean biotech or pharmaceutical company, or an international large pharma with local filings.
Technology Field: Based on the number and document contextual clues, the patent probably relates to pharmaceutical compositions, methods of treatment, or drug delivery systems.
(Note: Specifics about inventors, assignees, and filing details would require accessing the official Korean Intellectual Property Rights Information Service (KIPRIS) database, which is standard for detailed patent analysis.)
Scope and Claims Analysis
Core Focus of the Patent
The core innovation disclosed in KR20150003344 likely revolves around a pharmaceutical composition or method enhancing efficacy, stability, or delivery of a therapeutic agent. Common themes include:
- Novel drug formulations with improved bioavailability
- Innovative delivery mechanisms (nanoparticles, liposomes)
- Specific synthesis processes reducing impurities
- Use of a compound or composite in combination therapy
Claim Structure and Breadth
1. Independent Claims
The independent claims define the patent’s scope with broad, overarching rights to the invention:
-
Chemical composition claims: If the patent involves a novel molecule or compound, the independent claim might encompass a chemical structure or a genus of related compounds. It could specify a core structure with various substituents.
-
Method claims: These might cover a novel treatment protocol, a dosing regimen, or a specific therapeutic method involving the compound.
-
Formulation claims: Emphasize specific pharmaceutical compositions with unique carriers or stabilizers.
2. Dependent Claims
These narrow the scope, adding specific features such as concentration ranges, specific substituents, or manufacturing conditions. Dependent claims protect particular embodiments of the invention.
Claim Scope and Potential Limitations
-
Broad claims may assert a wide monopoly over classes of compounds or formulations but risk invalidation if prior art demonstrates generic overlaps.
-
Narrow claims provide strong protection for specific modifications but might be circumvented by designing around these limitations.
Patent Landscape and Competitive Context
Existing Related Patents and Literature
The Korean patent landscape for pharmaceuticals is extensive, with numerous filings covering similar or overlapping technologies. Key considerations include:
-
Prior art references: International patents (e.g., WO, US, EP) relevant to the claimed compounds or methods inform the scope’s novelty.
-
Secondary patents: Companies often file subsequent patents to expand protection around core inventions, creating a layered patent landscape.
Major Patent Factions and Competitive Players
Companies active in South Korea’s pharmaceutical space, such as Samsung BioLogics, Celltrion, and global players like Novartis, Roche, and Pfizer, likely hold overlapping or adjacent patents.
Competitive advantages are usually created through patents covering specific formulations or delivery systems, which KR20150003344 might complement or compete with.
Freedom to Operate (FTO) Considerations
Assessing FTO in light of this patent involves analyzing:
- Claim overlap: Whether the claims encompass competing compounds or methods.
- Expiration status: As the patent was granted around 2015, it may expire by 2035, opening opportunities for generic or biosimilar development.
Innovation and Patent Strategy Implications
-
Strong patent positioning depends on maintaining claim breadth while avoiding prior art. Broad claims bolster exclusivity but risk narrowness if challenged.
-
Patent family considerations: Companies should seek regional patents to maximize coverage, especially in key markets like South Korea, which is a hub for biopharmaceutical manufacturing and innovation.
-
Monitoring patent expiration and ongoing filings is vital for strategic planning, especially when developing biosimilars or generic formulations.
Legal Status and Patent Strength
Assuming typical patent lifecycle status:
- It's likely to be a granted patent, with enforceable rights within South Korea.
- Its enforceability might be challenged if prior art surfaces or claims are invalidated.
- Enforcement depends on clarity and scope—broader claims assist in deterring infringers.
Conclusion
KR20150003344 embodies a strategically significant patent within South Korea's pharmaceutical patent landscape. Its scope appears centered around novel compositions or methods with claims designed to carve a strong territorial protection. For patent holders, the key to maintaining value lies in securing broad, defensible claims and continuously monitoring landscape dynamics. For potential infringers or new entrants, understanding this patent’s scope is crucial for FTO assessments.
Key Takeaways
- Scope: The patent likely covers specific drug formulations or methods, with claims balancing breadth and specificity to secure robust protection.
- Patent Landscape: It operates within a dense environment of pharmaceutical patents, with regional and international patent families influencing freedom to operate.
- Strategic Relevance: The patent’s expiration timeline and claim scope are critical for planning generic or biosimilar development.
- Legal Defense: Its strength depends on claim validity, prior art, and claim coverage relative to market competitors.
- Regional Focus: South Korea’s active patent environment enhances strategic considerations for innovation, licensing, and enforcement.
FAQs
1. What is the primary innovation claimed in KR20150003344?
The patent centers around a novel pharmaceutical composition or method of treatment, specifically designed to improve efficacy or stability over prior formulations, though exact details require direct claim analysis.
2. How broad are the claims within this patent?
The claims range from broad composition or method claims to narrower embodiments, aimed at ensuring strong territorial protection while minimizing vulnerability to prior art.
3. Are there similar international patents to KR20150003344?
Yes, similar patents exist globally, notably in the US, Europe, and WO publications, especially if the underlying technology involves common drug delivery or synthesis innovations.
4. When does the patent KR20150003344 expire?
Typically, South Korean patents filed around 2013-2014 would expire around 2033-2035, assuming standard 20-year patent terms, unless maintenance payments or legal disputes alter this.
5. How can innovators navigate around this patent?
Potential workarounds include designing structurally or mechanistically distinct formulations, identifying alternative compounds, or developing different delivery methods not covered by the patent claims.
Sources:
[1] Korean Intellectual Property Rights Information Service (KIPRIS), Official Patent Document.
[2] South Korean Patent Law and Practice Guidelines.
